Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2024-07-09 Interim / Quarterly Rep…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Quarterly Update - Cxbladder Test Volumes Steady in Q1 25 11 pages 1.7MB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed quarterly update from Pacific Edge, focusing on test volumes for Q1 2025, sales force performance, pricing proposals to CMS, and clinical study updates. It includes financial and operational metrics for the quarter ending June 2024, discusses Medicare reimbursement issues, and provides management commentary on business outlook and strategy. The presence of substantive financial and operational data for a quarter, along with management analysis, indicates this is a comprehensive interim/quarterly report rather than a brief announcement or presentation. The document length (15,000 characters) and detailed content confirm it is not a short announcement or regulatory filing. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2024-07-09 English
ASX Appendix 3H - Options Lapsed
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities (options) for Pacific Edge Limited. It includes specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is a formal announcement related to changes in the company's securities, specifically the cessation of certain options. This type of document corresponds to a regulatory announcement about securities changes rather than a financial report or management discussion. Given the nature of the content and the ASX Appendix 3H form reference, this fits best under the category of Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA). However, since it concerns cessation (lapse) of securities and changes in issued capital, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is 3905 characters, which is short and focused on a specific capital change event, not a full report or announcement of a report publication.
2024-07-09 English
Notification of cessation of securities - PEB 4 pages 14.8KB
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Pacific Edge Limited dated July 9, 2024, detailing the cessation of certain securities (options) due to lapse of conditional rights. It provides specifics on the securities that have ceased, reasons for cessation, and updated issued capital figures. The content is focused on changes in the company's issued capital and securities status rather than financial results, management changes, or regulatory filings. The document is relatively short (3879 characters) and structured as an official notification to the ASX about securities ceasing to exist. This fits the definition of a Share Issue/Capital Change announcement, which covers new share issues, stock splits, or other capital changes including cessation of securities.
2024-07-08 English
Annual Report 2024
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2024' and contains detailed financial and operational performance information for the full fiscal year ending March 31, 2024. It includes comprehensive sections such as Chairman's report, CEO's report, financial highlights, governance, risk analysis, remuneration, financial statements, and auditor's report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. The document also references audited consolidated financial statements and compliance with accounting standards. These characteristics align with the definition of an Annual Report (10-K equivalent). Therefore, the correct classification is Annual Report (10-K). FY 2024
2024-06-27 English
Annual Report 2024 69 pages 7.7MB
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2024' and contains detailed financial and operational performance information for the full fiscal year ending March 31, 2024. It includes comprehensive sections such as Chairman's report, CEO's report, financial highlights, governance, risk analysis, remuneration, financial statements, and auditor's report. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes audited consolidated financial statements and detailed management commentary, consistent with an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2024-06-26 English
Cash Burn Slows; Coverage Catalysts in Focus
Annual Report Classification · 95% confidence The document is titled 'AUDITED FINANCIAL RESULTS FOR THE YEAR TO 31 MARCH 2024' and contains detailed financial and operational performance data for the full fiscal year ending March 31, 2024. It includes revenue figures, net loss, cash burn, strategic highlights, governance updates, and outlook commentary. The length is substantial (over 14,000 characters), and it contains comprehensive financial results and management discussion. It is not merely an announcement of a report or a certification. The presence of full-year financial data and detailed analysis indicates this is a full Annual Report. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2024
2024-05-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.